
Carmel physician wins $2M from Ascension for breach of contract, interference
The jury deliberated for about three hours before returning a verdict in favor of Dr. Timothy Story, ending a lawsuit that lasted for about 3-1/2 years.
The jury deliberated for about three hours before returning a verdict in favor of Dr. Timothy Story, ending a lawsuit that lasted for about 3-1/2 years.
In response, an Indianapolis medical practice is trying to train more early-career physicians in the field of hematology to reverse the trend of dwindling numbers of physicians entering the field.
Growth has come chiefly from a series of mergers, including one earlier this year with Denver-based Everside Health.
The new funding, for an advanced manufacturing and drug development center, will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion.
The 108-year-old foundation said its new plan will go beyond traditional grantmaking to work with local leaders and residents to bring about an end to unfair systems.
Elevance said it plans make its investment at two locations: its headquarters at 220 Virginia Avenue and another site at 4740 Victory Lane on the southeast side.
Indiana physicians are keeping an eye on the trend of large insurers dropping medical practices from their networks, which they call a classic case of David versus Goliath.
More than 6,000 people have filed claims against Cook in connection with its inferior vena cava filters, which are small, metal, cage-like devices inserted into a vein that returns blood from the lower half of the body to the heart.
When the hospital opened its doors in 1908, Theodore Roosevelt was in the White House. It is being replaced by a $4.3 billion hospital project directly to the south.
The Indianapolis-based drugmaker filed a suit in federal court this month, challenging the U.S. Food and Drug Administration’s ruling that the company’s experimental obesity treatment not a biological product.
Zenrelia is one of several drugs Elanco has in its pipeline that it predicts could reach blockbuster status, which in animal health means more than $100 million in annual sales.
The Joint Center of Excellence for Point of Care Precision Medicine aims to develop better personalized care for patients with diabetes, cancer, Alzheimer’s disease and pediatric rare disease.
Corteva, the Indianapolis-based seed and crop protection giant, formed a joint venture with the startup, Pairwise, based in Durham, North Carolina, aimed at increasing crop yield for food, fuel and fiber production.
Stephen Boehm has spent decades studying addictions and binge drinking, and was longtime professor and chair of the Indiana University Indy psychology department.
Nationally, the average cost of employer-sponsored health plans is expected to grow 9% next year if companies don’t find ways to cut costs, according to an Aug. 15 report by professional services firm Aon.
Four-year-old Novusterra Inc. is planning an initial public offering within 90 days and hopes to be approved to trade on the OTCQB Venture Market, often used by companies that are still developing.
The university plans to launch degree programs in occupational therapy, physical therapy and other rehabilitative health care services, and expand undergraduate and graduate nursing programs, with additional locations.
The Richard M. Fairbanks Foundation said the grants are part of a $14 million initiative to reverse declining college enrollment.
Lilly said its new option will help millions of adults with obesity access the medicine they need, including those not eligible for the Zepbound savings card program, those without employer coverage, and those who need to self-pay outside of insurance.
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.